During the past decade, Austin Neuromuscular Center conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 6 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 5 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Austin Neuromuscular Center" #1 sponsor was "Helixmith Co., Ltd." with 2 trials, followed by "University of Kansas Medical Center" with 2 trials sponsored, "Alexion" with 1 trials sponsored, "Alnylam Pharmaceuticals" with 1 trials sponsored and "Amylyx Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Neuromuscular Center" #1 collaborator was "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator, "Takeda Development Center Americas, Inc." with 1 trials as a collaborator, "University of Missouri-Columbia" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Austin Neuromuscular Center" are "Amyotrophic Lateral Sclerosis" (8 trials), "ALS" (2 trials), "Dermatomyositis" (2 trials), "Motor Neuron Disease" (2 trials) and "ATTR Amyloidosis With Cardiomyopathy" (1 trials). Many other conditions were trialed in "Austin Neuromuscular Center" in a lesser frequency.

Most popular intervention types in "Austin Neuromuscular Center" are "Drug" (19 trials), "Other" (7 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Engensis" (2 trials), "(RS)-baclofen, naltrexone hydrochloride and D-sorbitol" (1 trials), "0.25% albumin placebo solution with rHuPH20" (1 trials) and "AMX0035" (1 trials). Other intervention names were less common.

The vast majority of trials in "Austin Neuromuscular Center" are 21 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Austin Neuromuscular Center". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Austin Neuromuscular Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Austin Neuromuscular Center, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".